These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 26355291

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Respiratory morbidity in preterm infants predicted by natriuretic peptide (MR-proANP) and endothelin-1 (CT-proET-1).
    Gerull R, Neumann RP, Atkinson A, Bernasconi L, Schulzke SM, Wellmann S.
    Pediatr Res; 2022 May; 91(6):1478-1484. PubMed ID: 33958715
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular biomarkers pro-atrial natriuretic peptide and pro-endothelin-1 to monitor ductus arteriosus evolution in very preterm infants.
    Grass B, Baumann P, Arlettaz R, Fouzas S, Meyer P, Spanaus K, Wellmann S.
    Early Hum Dev; 2014 Jun; 90(6):293-8. PubMed ID: 24661445
    [Abstract] [Full Text] [Related]

  • 4. N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study.
    Rodríguez-Blanco S, Oulego-Erroz I, Alonso-Quintela P, Terroba-Seara S, Jiménez-González A, Palau-Benavides M.
    Pediatr Pulmonol; 2018 Aug; 53(8):1073-1081. PubMed ID: 29790673
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased ADMA levels are associated with poor pulmonary outcome in preterm neonates.
    Kavurt S, Demirel N, Bas AY, Ulubas Isık D, Ozcan B, Aydemir O.
    J Matern Fetal Neonatal Med; 2017 Apr; 30(7):864-869. PubMed ID: 27268203
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
    Sellmer A, Hjortdal VE, Bjerre JV, Schmidt MR, McNamara PJ, Bech BH, Henriksen TB.
    PLoS One; 2015 Apr; 10(10):e0140079. PubMed ID: 26452045
    [Abstract] [Full Text] [Related]

  • 16. Role of NT-proBNP in the prediction of moderate to severe Bronchopulmonary Dysplasia in preterm infants.
    Khan S, Concina VA, Schneider D, Westgate P, Arriagada S, Bada H.
    Pediatr Pulmonol; 2020 Feb; 55(2):376-382. PubMed ID: 31869001
    [Abstract] [Full Text] [Related]

  • 17. [Risk factors, frequency and severity of bronchopulmonary dysplasia (BPD) diagnosed according to the new disease definition in preterm neonates].
    Woynarowska M, Rutkowska M, Szamotulska K.
    Med Wieku Rozwoj; 2008 Feb; 12(4 Pt 1):933-41. PubMed ID: 19471069
    [Abstract] [Full Text] [Related]

  • 18. Revisiting the Definition of Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory Support for Preterm Neonates.
    Isayama T, Lee SK, Yang J, Lee D, Daspal S, Dunn M, Shah PS, Canadian Neonatal Network and Canadian Neonatal Follow-Up Network Investigators.
    JAMA Pediatr; 2017 Mar 01; 171(3):271-279. PubMed ID: 28114678
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.